- Home
- / 3sbio
3sbio
Stock Price
$6.1
2024-10-29
Market Capitalization
$14.1 B
2024-10-29
Revenue
¥7.8 B
FY, 2023
3sbio Summary
Company Summary
- Overview
- 3sbio (三生制药集团) is a company that develops biopharmaceuticals. Its product lineup covers several treatment fields including cancer, autoimmune, kidney disease, metabolism, and dermatology.
- Type
- Public
- Status
- Active
- Founded
- 1993
- HQ
- Shenyang, CN | view all locations
- Website
- http://www.3sbio.com/
- Cybersecurity rating
- ESG rating
Table of Contents
3sbio Financials
Summary Financials
- Revenue (FY, 2023)
- ¥7.8B
- Gross profit (FY, 2023)
- ¥7.1B
- Net income (FY, 2023)
- ¥1.6B
- Cash (FY, 2023)
- ¥2.7B
- EBIT (FY, 2023)
- ¥2.4B
- Enterprise value
- $16.2B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2025